Mapping the latent CRBN-molecular glue degrader interactome

ABSTRACT Molecular glue degraders (MGDs) are a transformative modality in drug discovery. MGDs that work in concert with the E3 ligase CRL4 CRBN can degrade a range of substrates through tailored MGDs. To explore CRL4 CRBN reprogrammability, we tested whether reported CRBN-MGD substrates are part of a network of latent CRBN interactors, detectable with generic CRBN-MGDs. Leveraging highly parallel interaction measurement (GluePCA) between CRL4 CRBN and human zinc-fingers (ZFs), we identified ∼210 ZFs bound to CRBN-pomalidomide, where top binders are already reported as degraded by dedicated MGDs. To map latent CRBN-MGDs interactions proteome-wide, and thus define the immediately accessible CRBN target space, we combined AI-derived protein surface queries (MaSIF-mimicry) with GluePCA. This pipeline identified 6 known and 43 novel CRBN-pomalidomide binders, thereby providing privileged starting points for MGD development. We expect this binding-focused, highly parallel workflow to be readily applicable to other MGD/E3 ligase systems, extending the target landscape of this emerging drug class.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2025-12-02
DOI
https://doi.org/10.64898/2025.12.02.691773
Primary Topic
Protein Degradation and Inhibitors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mapping the latent CRBN-molecular glue degrader interactome

Yanxiang Meng, Andreas Scheck, Dominique Klein, Kenji Shimada et al.
bioRxiv (Cold Spring Harbor Laboratory)
Protein Degradation and Inhibitors
article

Mapping the latent CRBN-molecular glue degrader interactome

Yanxiang Meng, Andreas Scheck, Dominique Klein, Kenji Shimada, Anna M. Díaz-Rovira, Pius Galli, Lukas Kater, Simone Cavadini, Bruno E. Correia, Jacob D. Aguirre, Maximilian R. Stammnitz, Alexandra M. Bendel, Georg Kempf, Nicolas H. Thomä, Guillaume Diss, Alexander Hanzl, Shuhao Xiao, Wei Ye
article en

Abstract

ABSTRACT Molecular glue degraders (MGDs) are a transformative modality in drug discovery. MGDs that work in concert with the E3 ligase CRL4 CRBN can degrade a range of substrates through tailored MGDs. To explore CRL4 CRBN reprogrammability, we tested whether reported CRBN-MGD substrates are part of a network of latent CRBN interactors, detectable with generic CRBN-MGDs. Leveraging highly parallel interaction measurement (GluePCA) between CRL4 CRBN and human zinc-fingers (ZFs), we identified ∼210 ZFs bound to CRBN-pomalidomide, where top binders are already reported as degraded by dedicated MGDs. To map latent CRBN-MGDs interactions proteome-wide, and thus define the immediately accessible CRBN target space, we combined AI-derived protein surface queries (MaSIF-mimicry) with GluePCA. This pipeline identified 6 known and 43 novel CRBN-pomalidomide binders, thereby providing privileged starting points for MGD development. We expect this binding-focused, highly parallel workflow to be readily applicable to other MGD/E3 ligase systems, extending the target landscape of this emerging drug class.

bioRxiv (Cold Spring Harbor Laboratory)
University of Basel (CH), Barcelona Supercomputing Center (ES), Barcelona Institute of Science and Technology (ES), Centre for Genomic Regulation (ES), École Polytechnique Fédérale de Lausanne (CH), Friedrich Miescher Institute (CH), Universitat Politècnica de Catalunya (ES)
Openalex Percentile: Top 65%
Protein Degradation and Inhibitors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.